aracteristics of treated and untreated FH patients.

Data are expressed as mean ± standard deviation unless otherwise indicated. Variables are based on information at time of molecular FH diagnosis in 2006 (baseline) unless otherwise indicated. Follow-up is at completion of the questionnaire in 2008.
ApoB = apolipoprotein B; CVD = cardiovascular disease; HDL-C = high-density lipoprotein cholesterol; IQR = interquartile range; LDL-C = low-density lipoprotein cholesterol; LDLR = LDL-receptor; TC = total cholesterol. #Estimated LDL-C with correction for treatment potency at diagnosis when applicable; *Based on mean LDL-C of treated (n = 397) and untreated (n = 239) levels; an = 441; bn = 51; cn = 262; dn = 35, en = 397.